The ATS provided guidance on how health care systems facing shortages can conserve IV fluids and address the shortages. Tips include: Reconfigure electronic health records to guide appropriate ...
Patients with EGFR-mutant, oligometastatic NSCLC who received radiotherapy plus icotinib had longer overall and progression-free survival than those who received icotinib alone.
Long-term results support the use of capmatinib to treat both treatment-naive and previously treated patients with non-small cell lung cancer (NSCLC) who have MET exon 14 skipping mutations ( MET ex14 ...